Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

Trading Update

19 Feb 2018 07:00

RNS Number : 2024F
BATM Advanced Communications Ld
19 February 2018
 

LEI: 213800FLQUB9J289RU66

 

19 February 2018

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Trading Update

FY 2017 results expected to be ahead of market expectations

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following update on trading for the year ended 31 December 2017 ahead of the publication of the Group's full year 2017 results on 5 March 2018.

 

The Group had a very successful second half of the year with both of its divisions gaining new customers, securing new contracts and expanding into new territories. As a result, the Group expects to report revenue for the year ended 31 December 2017 significantly ahead of market expectations at approximately $106m, representing year-on-year growth of approximately 17%. The Group also expects to report EBITDA of approximately $7.0m (2016: $2.8m). The 2017 EBITDA includes the benefit of profits on disposal of a wholly-owned building in December 2017 of approximately $5.6m (2016 EBITDA of $2.8m included the benefit of profits on disposal of another building of approximately $3.1m).

 

The increase in revenue was driven by growth in both of the Group's divisions. The Networking & Cyber division generated significantly better-than-expected sales largely due to growth in the Group's existing ICT services and solutions business as well as its success in implementing its strategy to leverage the telecom industry transition from hardware to Network Function Virtualisation ("NFV") and Software-Defined Networking ("SDN"). During the period, as previously announced, the Group established partnerships with a number of leading telecoms and semiconductor companies such as NXP and ARM, with the respective partners offering joint solutions for NFV/SDN. Revenue growth in the Bio-Medical division was driven by stronger sales in the distribution unit, mostly based on diagnostic and molecular biology products and services.

 

Further details will be provided in the Group's full year results announcement on 5 March 2018.

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKFDDDBKDNBD
Date   Source Headline
11th Jun 201510:10 amRNSHolding(s) in Company
11th Jun 201510:07 amRNSHolding(s) in Company
27th May 20159:05 amRNSHolding(s) in Company
20th May 20157:00 amRNSDirector Shareholding
12th May 20157:01 amRNSTrading and Business Update
30th Apr 20153:07 pmRNSDirector/PDMR Shareholding
30th Apr 20151:57 pmRNSAnnual Financial Report
16th Apr 20151:41 pmRNSDirector/PDMR Shareholding
10th Mar 20157:02 amRNSPreliminary Results
5th Mar 20157:00 amRNSDe-listing from TASE
26th Feb 201511:41 amRNSNotice of Results
12th Feb 201512:03 pmRNSResult of EGM
2nd Feb 20157:00 amRNSDiagnostic Kit Granted Licence for Sale in China
26th Jan 20153:30 pmRNSDirector Declaration
21st Jan 20154:35 pmRNSNotice of EGM
6th Jan 20151:06 pmRNSDirector Share Purchase
15th Dec 20147:00 amRNSSenior Management Changes
11th Dec 20147:00 amRNSDirector/PDMR Shareholding
1st Dec 201410:03 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSBusiness Update and Appointment of Chairman
18th Nov 20147:00 amRNSBATM awarded contract by major mobile operator
27th Oct 20147:00 amRNSBATM launches world's first 10GE platform
23rd Sep 20142:45 pmRNSTotal Voting Rights
22nd Sep 201412:30 pmRNSHolding(s) in Company
10th Sep 201411:40 amRNSResult of AGM
8th Sep 20147:00 amRNSBATM invests in Opticul Diagnostics
18th Aug 201412:58 pmRNSNotice of AGM
7th Aug 20147:00 amRNSInterim results
30th Jul 20147:00 amRNSNotification of Results
30th Jul 20147:00 amRNSCyber Security Agreement and Contract Win
16th Jun 20147:00 amRNSBATM wins two telecoms contracts in the US
28th May 20149:15 amRNSHolding(s) in Company
12th May 20147:00 amRNSBATM deploys surveillance solution in Islington
7th May 201412:25 pmRNSHolding(s) in Company
6th May 20147:01 amRNSInterim Management Statement
30th Apr 20141:22 pmRNSAnnual Financial Report
11th Apr 201410:45 amRNSHolding(s) in Company
7th Apr 201411:00 amRNSHolding(s) in Company
28th Mar 201411:00 amRNSHolding(s) in Company
12th Mar 20148:24 amRNSHolding(s) in Company
25th Feb 20147:00 amRNSPreliminary Results
17th Feb 20147:00 amRNSNotice of Results and Webcast
9th Jan 20144:15 pmRNSHolding(s) in Company
7th Jan 20147:00 amRNSTrading and Business Update
2nd Jan 201410:53 amRNSHolding(s) in Company
13th Dec 20134:30 pmRNSHolding(s) in Company
10th Dec 20135:10 pmRNSHolding(s) in Company
21st Nov 20138:30 amRNSHolding(s) in Company
20th Nov 20139:00 amRNSHolding(s) in Company
12th Nov 20137:00 amRNSBATM to join further Tel Aviv Stock Exchange index

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.